SCHEMBL20482379

SCHEMBL20482379

COC(=O)C1(Cc2ccc(Cl)c(OC)c2)CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ITGB1 P05556 4/20 0.46
▸ ITGA4 P13612 4/20 0.46
▸ KMT2A Q03164 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ POLB P06746 1/20 0.40
▸ ACACB O00763 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 2/20 0.39
▸ P2RX7 Q99572 2/20 0.39
▸ TSHR P16473 3/20 0.39
▸ MCOLN3 Q8TDD5 1/20 0.39
▸ CASP1 P29466 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ KCNH2 Q12809 2/20 0.38
▸ GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20482573 0.88 ITGB1 (0.46) ITGB1ITGA4KMT2AMEN1ACACB
SCHEMBL8586015 0.78 ALDH1A1 (0.52) ITGB1ITGA4KMT2AMEN1POLB
SCHEMBL20482975 0.77 TSHR (0.40) KMT2AMEN1ALDH1A1TSHRMCOLN3
SCHEMBL20482446 0.76 TSHR (0.38) ITGB1ITGA4KMT2AACACBALDH1A1
SCHEMBL28840825 0.75 CYP4F2 (0.42) KMT2APOLBALDH1A1P2RX7
SCHEMBL12353911 0.75 CYP4F2 (0.44) KMT2AMEN1POLBALDH1A1LMNA
SCHEMBL4907162 0.75 TACR1 (0.47) KMT2AMEN1ALDH1A1LMNATSHR
SCHEMBL5750629 0.75 POLB (0.46) KMT2APOLBALDH1A1LMNAP2RX7
SCHEMBL20482542 0.73 ITGB1 (0.41) ITGB1ITGA4KMT2AMEN1ALDH1A1
SCHEMBL30683842 0.73 TACR1 (0.48) KMT2AMEN1ALDH1A1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018154466-A1 DIHYDROQUINOLIZINONES AS ANTIVIRALS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-08-30 — — WO disclosed
Send feedback